FemPulse Therapy for Overactive Bladder in Women

Completed · Not applicable

Conditions studied: Urinary Bladder, Overactive

In brief

The purpose of this clinical trial is to investigate a new medical device treatment for Overactive Bladder (OAB) in women.

Key facts

Study ID

NCT03784170

Run by

FemPulse Corporation

People needed

21

Starts

2018-12-11

Expected to finish

2019-12-31

Last updated by the study team

2026-02-06

Who can join

Age: 21 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Females 21 years or older with a diagnosis of Overactive Bladder
• If of reproductive age, must use a reliable form of contraception

You may not qualify if…

• Pregnant, was recently pregnant or is trying to conceive
• Has a metal pelvic implant or any electrically active implanted medical device
• Had a previous hysterectomy, pelvic radiation or pelvic cancer
• Has significant pelvic organ prolapse
• Had bladder treatment with onabotulinumtoxinA in the previous 12 months
• Has a significant heart condition

Where it is running

• Minnesota Urology — Woodbury, Minnesota, United States
• McKay Urology — Charlotte, North Carolina, United States
• University of Washington Medical Center — Seattle, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.